Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
Autorzy:
Loginov VI; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia. Pronina IV; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia. Filippova EA; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia. Burdennyy AM; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia. Lukina SS; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia. KazubskayaTP; N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia. Uroshlev LA; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.; Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia. Fridman MV; Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia. Brovkina OI; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia. Apanovich NV; Research Center for Medical Genetics, 115478 Moscow, Russia. Karpukhin AV; Research Center for Medical Genetics, 115478 Moscow, Russia. Stilidi IS; N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia. Kushlinskii NE; N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia. Dmitriev AA; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. Braga EA; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma.
Autorzy:
Alekseeva EA; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia.; Laboratory of Medical Genetics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119992 Moscow, Russia. Babenko OV; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia. Kozlova VM; Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 115478 Moscow, Russia. Ushakova TL; Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 115478 Moscow, Russia.; Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia. KazubskayaTP; Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 115478 Moscow, Russia. Nemtsova MV; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia.; Laboratory of Medical Genetics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119992 Moscow, Russia. Chesnokova GG; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia. Mikhaylenko DS; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia.; Laboratory of Medical Genetics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119992 Moscow, Russia. Bure IV; Laboratory of Medical Genetics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119992 Moscow, Russia. Kalinkin AI; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia. Kuznetsova EB; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia.; Laboratory of Medical Genetics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119992 Moscow, Russia. Tanas AS; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia. Kutsev SI; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia. Zaletaev DV; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia. Strelnikov VV; Laboratory of Epigenetics, Research Centre for Medical Genetics, 115522 Moscow, Russia.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Oct 10; Vol. 13 (20). Date of Electronic Publication: 2021 Oct 10.
Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.
Autorzy:
Loginov VI; Laboratory of Pathogenomics and Transcriptomics, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315, Moscow, Russia; Laboratory of Molecular Genetics of Complex Inherited Diseases, Research Center of Medical Genetics, Russian Academy of Medical Sciences, 115478, Moscow, Russia. Dmitriev AA; Laboratory of Structural and Functional Genomics, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia; Department of Pathomorphology, P.A. Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, 125284, Moscow, Russia. Senchenko VN; Laboratory of Structural and Functional Genomics, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia. Pronina IV; Laboratory of Pathogenomics and Transcriptomics, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315, Moscow, Russia; Laboratory of Molecular Genetics of Complex Inherited Diseases, Research Center of Medical Genetics, Russian Academy of Medical Sciences, 115478, Moscow, Russia. Khodyrev DS; Laboratory of Genetics, Federal Research Clinical Center of Federal Medical and Biological Agency of Russia, 115682, Moscow, Russia. Kudryavtseva AV; Laboratory of Structural and Functional Genomics, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia; Department of Pathomorphology, P.A. Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, 125284, Moscow, Russia. Krasnov GS; Laboratory of Structural and Functional Genomics, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia; Laboratory of Biotechnology, Mechnikov Research Institute for Vaccines and Sera, Russian Academy of Medical Sciences, 105064, Moscow, Russia. Gerashchenko GV; Department of Molecular Oncogenetics, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 03680, Kiev, Ukraine. Chashchina LI; Department of Molecular Oncogenetics, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 03680, Kiev, Ukraine. KazubskayaTP; Research Institute of Clinical Oncology, N.N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, 115478, Moscow, Russia. Kondratieva TT; Research Institute of Clinical Oncology, N.N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, 115478, Moscow, Russia. Lerman MI; Scientific Board, Affina Biotechnologies, 06902, Stamford, CT, USA. Angeloni D; The Institute of Life Sciences, Scuola Superiore Sant'Anna, 56127, Pisa, Italy; Institute of Clinical Physiology, National Research Council, 56124, Pisa, Italy; Istituto Toscano Tumori, 56124, Pisa, Italy. Braga EA; Laboratory of Pathogenomics and Transcriptomics, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315, Moscow, Russia; Laboratory of Molecular Genetics of Complex Inherited Diseases, Research Center of Medical Genetics, Russian Academy of Medical Sciences, 115478, Moscow, Russia; Laboratory of Post Genomic Molecular Genetic Research, Institute of Biochemical Physics, Russian Academy of Sciences, 119334, Moscow, Russia. Kashuba VI; Department of Molecular Oncogenetics, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 03680, Kiev, Ukraine; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, SE-17177, Stockholm, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 May 11; Vol. 10 (5), pp. e0123369. Date of Electronic Publication: 2015 May 11 (Print Publication: 2015).
Upregulation of RHOA and NKIRAS1 genes in lung tumors is associated with loss of their methylation as well as with methylation of regulatory miRNA genes.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies